Benzinga | Jun 30, 2021 04:51PM EDT

'Halftime Report' Traders Share Their Thoughts On Crispr Therapeutics And Bed Bath & Beyond

Amy Raskin said on CNBC's "Fast Money Halftime Report" that she would hold Crispr Therapeutics AG (NASDAQ:CRSP). She doesn't own the stock, but she owns Intellia Therapeutics Inc (NASDAQ:NTLA) in the space.

Pete Najarian sees Bed Bath & Beyond Inc. (NASDAQ:BBBY) as a trading vehicle because of volatile trading. A lot of that has to do with the short interest of the company.